Dr. Donald G. Basile - 22 Aug 2023 Form 4 Insider Report for CompoSecure, Inc. (CMPO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Aug 2023, 18:48:22 UTC
Prior SEC filing
24 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dr. Donald G. Basile

Key filing fact

Dr. Donald G. Basile filed Form 4 for CompoSecure, Inc. (CMPO) on 24 Aug 2023.

Key facts

  • This page summarizes Dr. Donald G. Basile's Form 4 filing for CompoSecure, Inc. (CMPO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 24 Aug 2023, 18:48.

Change

  • Previous filing in this sequence was filed on 24 Jul 2023.
  • Current net transaction value: -$506,484.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMPO transaction Derivative

Warrant

Sale

Transaction value
$506,484
Shares
-7,792,056
Change %
-96%
Price
$0.0650*
Shares after
300,000
Date
22 Aug 2023
Ownership
See footnote
Underlying class
Class A Common Stock
Underlying amount
7,792,056
Exercise price
$11.50
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Dr. Donald G. Basile is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $0.65 to $0.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the range set forth in this footnote.

Footnote F2

As a managing member of Roman DBDR Tech Sponsor LLC (the "Sponsor"), the reporting person may be deemed to share beneficial ownership of the shares of Class A Common Stock held directly by the Sponsor, and disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .